Prediction and Prevention of Cancer-Associated Thromboembolism is organized by Society for Translational Oncology (STO).
Released: 1/13/2021
Expires: 12/14/2022
Learning Objectives:
• Assess VTE risk in patients with cancer.
• Describe best practices for the use of thromboprophylaxis in patients with cancer.
Additional details will be posted as soon as information is available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved